Notable Labs, Ltd. (NASDAQ:NTBL) Sees Large Increase in Short Interest

Notable Labs, Ltd. (NASDAQ:NTBL) was the recipient of a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 622,000 shares, an increase of 22.0% from the August 31st total of 509,900 shares. Based on an average trading volume of 89,400 shares, the short-interest ratio is currently 7.0 days. Approximately 12.0% of the shares of the stock are sold short.

Notable Labs Price Performance

NTBL stock traded down $0.02 during midday trading on Monday, reaching $0.43. 68,231 shares of the stock were exchanged, compared to its average volume of 232,454. Notable Labs has a 52 week low of $0.40 and a 52 week high of $10.08. The company has a current ratio of 2.77, a quick ratio of 2.77 and a debt-to-equity ratio of 0.03. The company has a fifty day moving average price of $0.53 and a 200 day moving average price of $0.85.

Notable Labs (NASDAQ:NTBL) last announced its earnings results on Wednesday, August 14th. The company reported ($0.55) EPS for the quarter. On average, sell-side analysts anticipate that Notable Labs will post -0.75 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, JMP Securities lowered Notable Labs from an “outperform” rating to a “market perform” rating in a research note on Friday, September 20th.

Notable Labs Company Profile

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment.